Ajit Jadhav

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 7 CIPO patents and 11 EPO patents, primarily in Cancer Therapeutics. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The UAB Research Foundation (The University of Alabama at Birmingham), University of Pennsylvania. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ajit Jadhav. Retrieved from https://idiyas.com/inventor/ajit-jadhav

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 81.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 27(Granted Patents)

Company Filing History:

19 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6 out of 641

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

6 out of 2,663

University of Pennsylvania

patents

4. 6 out of 1,223

Vanderbilt University

patents

5. 4 out of 16,048

University of California

Eastern Virginia Medical School

patents

8. 3 out of 539

Thomas Jefferson University

patents

9. 2 out of 1,217

The United States of America as Represented by the Department of Health

patents

10. 2 out of 1,330

The University of North Carolina at Chapel Hill

University of Delaware

patents

14. 1 out of 1,384

Washington University

patents

15. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Bromodomain Inhibitors

Lactate Dehydrogenase

Cancer Treatment

Mutant IDH1

12-Lipoxygenase

Pyridazinones

Thiazole Derivatives

Bicyclic Compounds

Viral Infection

Deubiquitinase Complex

Wolfram Syndrome

Endoplasmic Reticulum Stress

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497395 - Small molecule bromodomain inhibitors and uses therof (2025-12-16),

2. 12365653 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2025-07-22),

3. 11897845 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2024-02-13),

4. 11426415 - Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders (2022-08-30),

5. 11274077 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2022-03-15),

6. 11247971 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2022-02-15),

7. 11110089 - Pyridazinones and their use in the treatment of cancer (2021-09-07),

8. 11028079 - Small molecule BET bromodomain inhibitors and uses thereof (2021-06-08),

9. 10961200 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-30),

10. 10954228 - 1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-23),

11. 10899710 - Pyridines and their use in the treatment of cancer (2021-01-26),

12. 10881653 - Tricyclic compounds and their use in the treatment of cancer (2021-01-05),

13. 10836759 - Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer (2020-11-17),

14. 10752581 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2020-08-25),

15. 10703746 - Mutant IDH1 inhibitors useful for treating cancer (2020-07-07),

Title: Ajit Jadhav: Pioneering Innovator in Technology

Introduction:

Ajit Jadhav, a distinguished inventor based in Chantilly, VA (US), has been a trailblazer in the world of technology. With a remarkable dedication to innovation and a relentless pursuit of excellence, Jadhav has established himself as a prominent figure inspiring the next generation of inventors and innovators.

Latest Patents:

Jadhav's latest patents showcase his cutting-edge work in the field of technology. One of his recent inventions includes "Small molecule inhibitors of lactate dehydrogenase and methods of use thereof." This compound offers promising methods for treating cancer and inhibiting lactate dehydrogenase activity in cells. Another notable patent by Jadhav is related to the treatment of Wolfram syndrome and other endoplasmic reticulum stress disorders, providing innovative compositions and methods for combating these conditions.

Career Highlights:

Throughout his career, Ajit Jadhav has contributed significantly to the field of technology. With an impressive portfolio of 19 patents, his innovative spirit has led to groundbreaking advancements in various areas. Jadhav's commitment to pushing boundaries and exploring new frontiers has set him apart as a pioneer in the industry.

Collaborations:

Ajit Jadhav has collaborated with esteemed institutions and organizations during his innovative journey. Some of his notable coworkers include David Joseph Maloney and Anton Simeonov. Jadhav's collaborations with renowned entities like the United States of America, Department of Health and Human Services, and Vanderbilt University have further amplified the impact of his inventions.

Conclusion:

In conclusion, Ajit Jadhav's contributions to the world of technology are truly remarkable. His inventive spirit, paired with his unwavering commitment to excellence, has solidified his position as a pioneering innovator. Jadhav's groundbreaking patents and collaborative efforts stand as a testament to his profound impact on the industry, inspiring future generations to continue pushing the boundaries of innovation.

Profile summary based on public USPTO records.